We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$264B
AUM Growth
+$16.6B
Cap. Flow
-$3.28B
Cap. Flow %
-1.24%
Top 10 Hldgs %
18.75%
Holding
3,331
New
118
Increased
1,090
Reduced
1,840
Closed
95

Top Sells

Rank Stock Value
1
CSCO icon
Cisco
CSCO
+$474M
2
CELG
Celgene Corp
CELG
+$421M
3
AVGO icon
Broadcom
AVGO
+$411M
4
NFLX icon
Netflix
NFLX
+$387M
5
AAPL icon
Apple
AAPL
+$372M

Sector Composition

Rank Sector Weight
1 Technology 20.51%
2 Financials 14.64%
3 Healthcare 13.3%
4 Consumer Discretionary 10.29%
5 Communication Services 9.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RAVN
1976
DELISTED
Raven Industries Inc
RAVN
$5.17M ﹤0.01%
150,101
+3,734
+3% +$127K
DNOW icon
1977
DNOW Inc
DNOW
$2.99B
$5.15M ﹤0.01%
458,424
-11,279
-2% -$126K
FTSV
1978
DELISTED
Forty Seven, Inc. Common Stock
FTSV
$5.15M ﹤0.01%
130,856
+30,027
+30% +$482K
MATV icon
1979
Mativ Holdings
MATV
$711M
$5.15M ﹤0.01%
122,647
-883
-0.7% -$36.7K
RDY icon
1980
Dr. Reddy's Laboratories
RDY
$10.2B
$5.15M ﹤0.01%
634,180
-7,420
-1% -$58.6K
BMTC
1981
DELISTED
Bryn Mawr Bank Corp
BMTC
$5.13M ﹤0.01%
124,313
+31,262
+34% +$1.21M
MED icon
1982
Medifast
MED
$141M
$5.12M ﹤0.01%
46,712
-131,025
-74% -$12.7M
PLMR icon
1983
Palomar
PLMR
$3.45B
$5.11M ﹤0.01%
101,188
-253,016
-71% -$11.9M
GCO icon
1984
Genesco
GCO
$422M
$5.09M ﹤0.01%
106,304
-6,296
-6% -$261K
XRN
1985
Chiron Real Estate Inc
XRN
$477M
$5.09M ﹤0.01%
76,891
-2,940
-4% -$185K
VIVO
1986
DELISTED
Meridian Bioscience Inc
VIVO
$5.08M ﹤0.01%
520,425
+81,916
+19% +$769K
JBSS icon
1987
John B. Sanfilippo & Son
JBSS
$972M
$5.08M ﹤0.01%
55,635
+11,578
+26% +$1.12M
BBSI icon
1988
Barrett Business Services
BBSI
$804M
$5.08M ﹤0.01%
224,488
-7,172
-3% -$159K
CLDT
1989
Chatham Lodging
CLDT
$586M
$5.07M ﹤0.01%
276,313
+2,860
+1% +$51.6K
IGRO icon
1990
iShares International Dividend Growth ETF
IGRO
$1.32B
$5.07M ﹤0.01%
84,000
ENDP
1991
DELISTED
Endo International plc
ENDP
$5.07M ﹤0.01%
1,079,965
-59,791
-5% -$267K
LTHM
1992
DELISTED
Livent Corporation
LTHM
$5.06M ﹤0.01%
591,301
-4,951
-0.8% -$37.9K
HOUS
1993
DELISTED
Anywhere Real Estate
HOUS
$5.05M ﹤0.01%
521,972
-18,207
-3% -$167K
PJT icon
1994
PJT Partners
PJT
$4.38B
$5.04M ﹤0.01%
111,655
+16,684
+18% +$700K
SWCH
1995
DELISTED
Switch, Inc. Class A Common Stock
SWCH
$5.04M ﹤0.01%
339,994
-200,932
-37% -$3.05M
HLIO icon
1996
Helios Technologies
HLIO
$2.76B
$5.04M ﹤0.01%
108,940
-1,856
-2% -$79.6K
AUD
1997
DELISTED
Audacy, Inc.
AUD
$5.03M ﹤0.01%
1,083,443
+224,029
+26% +$936K
FSB
1998
DELISTED
Franklin Financial Network, Inc.
FSB
$5.02M ﹤0.01%
146,233
+39,281
+37% +$1.29M
BAND
1999
Bandwidth Inc
BAND
$1.61B
$5.02M ﹤0.01%
78,332
+13,231
+20% +$766K
SRCE icon
2000
1st Source
SRCE
$2.12B
$5M ﹤0.01%
96,460
-1,408
-1% -$70.7K

Similar funds

Nuveen's Q4 2019 Portfolio in Review

As of Q4 2019, Nuveen held 3,331 positions worth $264B, up 6.7% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Nuveen's Q4 2019 filing shows 118 new, 1,090 increased, 1,840 reduced and 95 closed positions. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B. The largest sale was Cisco, an estimated $474M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • Nuveen's largest Q4 2019 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B.
  • Nuveen added most to Bristol-Myers Squibb in Q4 2019, an estimated $649M increase.
  • Nuveen's biggest Q4 2019 reduction was Cisco, cutting an estimated $474M.
  • Nuveen fully exited Celgene Corp in Q4 2019, selling an estimated $421M.
  • Nuveen's ten largest holdings make up 19% of its $264B portfolio in Q4 2019.
  • Nuveen opened 118 new positions and closed 95 in Q4 2019.
  • Nuveen's portfolio value rose 6.7% quarter-over-quarter to $264B.

Based on Nuveen's 13F filing for Q4 2019, filed 14 Feb 2020.